Insider Trading March 4, 2026

Rocket Lab General Counsel Sells $3.7M in RKLB Shares as Company Posts Record Revenue

SVP and General Counsel Arjun Kampani disposed of 51,022 shares across two trading days amid a banner fiscal 2025 for Rocket Lab USA

By Caleb Monroe RKLB
Rocket Lab General Counsel Sells $3.7M in RKLB Shares as Company Posts Record Revenue
RKLB

Arjun Kampani, Rocket Lab Corp's SVP and General Counsel, sold 51,022 shares of common stock on March 2 and March 4, 2026, raising approximately $3.7 million. Transactions were executed across multiple tranches at prices between $66.8288 and $74.09. The company simultaneously reported record fiscal 2025 revenue of about $602 million and logged 21 successful launches, prompting analysts to adjust price targets and ratings.

Key Points

  • Arjun Kampani, SVP & General Counsel, sold 51,022 shares of Rocket Lab common stock on March 2 and March 4, 2026, for approximately $3.7 million.
  • Sales were executed across multiple tranches at prices ranging from $66.8288 to $74.09; after the transactions Kampani directly owns 397,988 shares.
  • Rocket Lab reported record fiscal 2025 revenue of about $602 million, driven by 21 successful launches; analysts adjusted price targets and ratings in response to the results.

Arjun Kampani, who serves as Senior Vice President and General Counsel at Rocket Lab Corp (NASDAQ: RKLB), completed the sale of 51,022 shares of common stock in two separate sessions on March 2 and March 4, 2026. The aggregate proceeds from those dispositions totaled roughly $3.7 million, with execution prices ranging from $66.8288 to $74.09 per share.

The divestitures were carried out in multiple transactions. On March 2, Kampani sold the following lots: 2,058 shares at a weighted average price of $66.8288; 1,451 shares at $67.9207; 5,284 shares at $69.1034; 16,792 shares at $70.0313; and 3,176 shares at $70.617. On March 4, the shares sold included 2,436 at $70.5156; 11,022 at $71.6184; 7,140 at $72.314; 3,013 at $73.3561; and 100 shares at $74.09.

After these transactions, Kampani is reported to directly hold 397,988 shares of Rocket Lab common stock. Company filings indicate that some of the sales were made to satisfy tax obligations tied to the vesting of restricted stock units, while other sales were executed pursuant to a pre-arranged Rule 10b5-1 trading plan.


These insider transactions come amid a period of strong operational performance for Rocket Lab USA. The company reported record fiscal 2025 revenue of approximately $602 million, a figure that surpassed both consensus estimates and the company's own guidance. The revenue milestone was supported by 21 successful space launches during the fiscal year, including seven launches in the fourth quarter - a quarterly record for the business.

Analysts reacted to the results with a mix of upward price-target revisions and recalibrated ratings. Cantor Fitzgerald raised its price target on Rocket Lab shares to $85 while maintaining an Overweight rating. Needham adjusted its price target to $95, noting a delay in the Neutron launch but also pointing to revenue outcomes that beat consensus by 2% in the fourth quarter and guidance for first-quarter revenue that was 4% above expectations.

On the revenue side, Rocket Lab's Space Systems segment posted a 29% year-over-year increase, while Launch revenue grew 38% in the fourth quarter. Craig-Hallum lifted its price target to $68, highlighting an increase in backlog but also noting the possibility of downward revisions to profitability. KeyBanc kept its Sector Weight rating in place, citing the Neutron launch delay now scheduled for the fourth quarter of 2026 - a six-month push from prior timing.

Taken together, the insider selling by a senior executive and the firm's record top-line performance have drawn attention from both the investment community and observers focused on aerospace and space systems markets. The sales were partly mechanics of compensation and tax management and partly the product of an established trading plan, while the company's financial and operational updates have prompted divergent analyst responses.


Summary of the transactions and company developments are rooted in publicly reported transaction data and official company financial disclosures. Details on the number of shares, per-share prices, and post-sale holdings reflect the filings related to the transactions.

Risks

  • Neutron launch delay to the fourth quarter of 2026 introduces schedule risk for Rocket Lab - this affects aerospace and space launch markets.
  • Potential downward revisions to profitability noted by analysts could impact investor expectations for margins in space systems and launch services.
  • Insider selling, even when partially for tax obligations or under a Rule 10b5-1 plan, can create short-term investor uncertainty in the stock - affecting capital markets sentiment for RKLB.

More from Insider Trading

Q2 Holdings COO Sells Shares to Satisfy RSU Tax Withholding Mar 4, 2026 Green Brick Partners Director Executes Mixed Transaction, Sells 2,500 Shares and Receives Restricted Grant Mar 4, 2026 Ligand Director Disposes $93.6K in Shares as Stock Trades Near Yearly High Mar 4, 2026 Roku Subscriptions President Disposes $310,602 in Shares After Option Exercise and RSU Conversions Mar 4, 2026 Major PBF Energy Stakeholder Disposes of $8.59 Million in Shares as Stock Nears 52-Week High Mar 4, 2026